Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Quest Diagnostics Incorporated (DGX)

140.06   4.67 (3.45%) 03-24 16:03
Open: 135.59 Pre. Close: 135.39
High: 141.28 Low: 134.96
Volume: 1,655,109 Market Cap: 15,592(M)

Technical analysis

as of: 2023-03-24 4:25:18 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 173.93     One year: 203.16
Support: Support1: 137.43    Support2: 130.33
Resistance: Resistance1: 148.91    Resistance2: 173.93
Pivot: 135.19
Moving Average: MA(5): 135.71     MA(20): 136.22
MA(100): 146.01     MA(250): 138.6
MACD: MACD(12,26): -2.1     Signal(9): -2.8
Stochastic oscillator: %K(14,3): 57.6     %D(3): 46.8
RSI: RSI(14): 54.7
52-week: High: 158.33  Low: 120.4
Average Vol(K): 3-Month: 1,169 (K)  10-Days: 1,351 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ DGX ] has closed below upper band by 1.1%. Bollinger Bands are 11.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 141.45 - 141.98 141.98 - 142.4
Low: 133.57 - 134.22 134.22 - 134.74
Close: 139.07 - 140.09 140.09 - 140.91

Company Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Headline News

Tue, 21 Mar 2023
First-of-Its-Kind Post-COVID-19 Panels Available at - Quest Diagnostics Newsroom

Sun, 19 Mar 2023
Validea's Top Ten Healthcare Stocks Based On Joel Greenblatt - 3 ... - Nasdaq

Thu, 16 Mar 2023
Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and ... - Quest Diagnostics Newsroom

Mon, 06 Mar 2023
Investing in Quest Diagnostics (NYSE:DGX) five years ago would have delivered you a 48% gain - Simply Wall St

Tue, 14 Feb 2023
Quest Diagnostics and NewYork-Presbyterian Agree to Laboratory ... - Quest Diagnostics Newsroom

Mon, 13 Feb 2023
Quest Diagnostics to Host Investor Day on March 16, 2023 - Quest Diagnostics Newsroom

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 111 (M)
Shares Float 110 (M)
% Held by Insiders 0.7 (%)
% Held by Institutions 93.7 (%)
Shares Short 3,320 (K)
Shares Short P.Month 2,740 (K)

Stock Financials

EPS 7.88
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 53.09
Profit Margin (%) 9.5
Operating Margin (%) 15.6
Return on Assets (ttm) 7.3
Return on Equity (ttm) 16.1
Qtrly Rev. Growth -15
Gross Profit (p.s.) 31.17
Sales Per Share 88.75
EBITDA (p.s.) 17.87
Qtrly Earnings Growth -71.7
Operating Cash Flow 1,720 (M)
Levered Free Cash Flow 1,050 (M)

Stock Valuations

PE Ratio 17.75
PEG Ratio -2
Price to Book value 2.63
Price to Sales 1.57
Price to Cash Flow 9.06

Stock Dividends

Dividend 0.66
Forward Dividend 0
Dividend Yield 0.4%
Dividend Pay Date 2022-02-01
Ex-Dividend Date 2022-01-17
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.